Viking Therapeutics
VKTX
VKTX
129 hedge funds and large institutions have $312M invested in Viking Therapeutics in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
9.79% more ownership
Funds ownership: 34.71% → 44.5% (+9.8%)
0% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 34
Holders
129
Holding in Top 10
1
Calls
$22.8M
Puts
$5.27M
Top Buyers
| 1 | +$14.1M | |
| 2 | +$12.2M | |
| 3 | +$12M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.4M |
| 5 |
D.E. Shaw & Co
New York
|
+$8.81M |
Top Sellers
| 1 | -$24.2M | |
| 2 | -$11.9M | |
| 3 | -$8.32M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.44M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$1.61M |